Holen Sie sich die Stockscreener-App
1.27
2.31%
-0.03
Handel nachbörslich:
1.28
0.01
+0.79%
Schlusskurs vom Vortag:
$1.30
Offen:
$1.3
24-Stunden-Volumen:
1.62M
Relative Volume:
2.68
Marktkapitalisierung:
$46.47M
Einnahmen:
$2.91M
Nettoeinkommen (Verlust:
$-220.40M
KGV:
-0.3489
EPS:
-3.64
Netto-Cashflow:
$-176.15M
1W Leistung:
-0.78%
1M Leistung:
-6.62%
6M Leistung:
-7.30%
1J Leistung:
-85.70%
1-Tages-Spanne:
$1.27
$1.30
1-Wochen-Bereich:
$1.27
$1.31
52-Wochen-Spanne:
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
Firmenname
Igm Biosciences Inc
Sektor
Branche
Telefon
650-965-7873
Adresse
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Vergleichen Sie IGMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.27 | 77.78M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-01-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-10-01 | Herabstufung | Truist | Buy → Hold |
| 2024-02-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | Fortgesetzt | Jefferies | Buy |
| 2022-10-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2021-12-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2021-08-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-22 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-07-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-07-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-28 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Wedbush | Outperform |
| 2019-10-14 | Eingeleitet | Guggenheim | Buy |
| 2019-10-14 | Eingeleitet | Jefferies | Buy |
| 2019-10-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-10-14 | Eingeleitet | Stifel | Buy |
Alle ansehen
Igm Biosciences Inc Aktie (IGMS) Neueste Nachrichten
IGM Biosciences Inc.’s Beta Climbs After Market VolatilityProven Entry Plan With Low Risk Shared - beatles.ru
Is IGM Biosciences Inc. stock a hidden gemPotential 10x Return Stocks - sisaissue.com
IGM Biosciences (IGMS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Is IGM Biosciences Inc. stock a top performer YTDGolden Triangle Formation Screener - thegnnews.com
IGM Biosciences earnings beat by $1.70, revenue topped estimates - Investing.com Canada
IGM Biosciences (NASDAQ:IGMS) Releases Quarterly Earnings Results, Beats Estimates By $1.88 EPS - MarketBeat
What are analysts’ price targets for IGM Biosciences Inc. in the next 12 monthsGet exclusive market insights for better trading - Jammu Links News
How strong is IGM Biosciences Inc. company’s balance sheetUnlock exclusive trading strategies - Jammu Links News
Is IGM Biosciences Inc. a good long term investmentGet exclusive access to expert stock recommendations - Jammu Links News
How does IGM Biosciences Inc. compare to its industry peersMaximize portfolio value with timely trades - Jammu Links News
Is it the right time to buy IGM Biosciences Inc. stockMaximize gains with expert analysis - Jammu Links News
When is IGM Biosciences Inc. stock expected to show significant growthFind market-beating stocks for your portfolio - Jammu Links News
What is the risk reward ratio of investing in IGM Biosciences Inc. stockBuild a diversified portfolio for sustainable growth - Jammu Links News
What catalysts could drive IGM Biosciences Inc. stock higher in 2025Access daily stock market expert updates - Jammu Links News
How many analysts rate IGM Biosciences Inc. as a “Buy”Get timely alerts on top-performing stocks - Jammu Links News
Chart based exit strategy for IGM Biosciences Inc.High Probability Trade Outcome Prediction - Newser
Sentiment Tools Show Shift in Trader Mood on IGM Biosciences Inc.Earnings Play Trade Plan With Alerts Shared - metal.it
IGM Biosciences 2025 Q2 Earnings Strong Performance as Net Income Swings 303.7% - AInvest
Is IGM Biosciences Inc. a candidate for recovery playScalable Strategy with Chart Confirmation - Newser
Custom watchlist performance reports with IGM Biosciences Inc.High Return Trade Roadmap with Setup Filters - Newser
IGM Biosciences Q2 2025 Earnings Report: Persistent Losses Amid Weak Earnings Beat Performance - AInvest
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates - sharewise.com
IGM Biosciences Surpasses Earnings and Revenue Estimates in Q2, Shares Down 79.4% YTD - AInvest
How does IGM Biosciences Inc. generate profit in a changing economyFree Stock Alerts For Every Investor - Jammu Links News
IGM Biosciences Q2 2025 Earnings Miss: A Harbinger of Persistent Pressure - AInvest
IGM Biosciences Inc. stock daily chart insightsAlpha Stock Picks with Chart Confirmation - Newser
Competitive Positioning of IGM Biosciences Inc.: Is It Leading or LaggingFree Oversold Bounce Stock Play Ideas - Newser
Why IGM Biosciences Inc. stock attracts strong analyst attentionFree Consistent Income Focused Trade List - Newser
Multi factor analysis applied to IGM Biosciences Inc.Predictable Return Plan with Entry Guidance - Newser
Key metrics from IGM Biosciences Inc.’s quarterly dataShort-Term Trade Setup with Forecast Insight - Newser
Volume spikes in IGM Biosciences Inc. stock – what they meanFree Low Risk Picks for Daily Trading - Newser
Predicting IGM Biosciences Inc. trend using moving averagesDeep Learning Stock Forecast for Investors - Newser
Mary Beth Harler Sells 14,501 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock - MarketBeat
What makes IGM Biosciences Inc. stock price move sharplyFree Accurate Technical Trend Reversal Picks - Newser
Insider Selling: IGM Biosciences, Inc. (NASDAQ:IGMS) CFO Sells 8,741 Shares of Stock - MarketBeat
Will IGM Biosciences Inc. Recover After Recent DeclineCapital Growth With Controlled Risk Picks Suggested - metal.it
Is IGM Biosciences Inc. a growth stock or a value stockCapitalize on market trends with confidence - jammulinksnews.com
Order flow analysis tools used on IGM Biosciences Inc. Free Trade Setups With Clear Risk Limits - Newser
Finanzdaten der Igm Biosciences Inc-Aktie (IGMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):